Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio L Cury

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Cureus|May 3, 2018
Abscopal Effect in a Stage IV Melanoma Patient who Progressed on PembrolizumabJames M Tsui, Catalin Mihalcioiu, Fabio L Cury
Expert Review of Anticancer Therapy|December 4, 2009
Organ-sparing strategies in the management of invasive bladder cancerFaysal A Yafi, Fabio L Cury, Wassim Kassouf
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 12, 2011
Radiation therapy and androgen deprivation in the management of high risk prostate cancerAlan Dal Pra, Fabio L Cury, Luis Souhami
CMAJ Open|August 1, 2014
Active surveillance for low-risk prostate cancer compared with immediate treatment: a Canadian cost comparisonAlice Dragomir, Fabio L Cury, Armen G Aprikian
Brachytherapy|February 13, 2010
Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapyFabio L Cury, Marie Duclos, Armen Aprikian, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2022
Meta-analysis of Elective Pelvic Nodal Irradiation Using Moderate Hypofractionation for High-Risk Prostate CancerGustavo A Viani, Andre G Gouveia, Fabio Y Moraes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2024
In reply to Niu et al: Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)Fabio L Cury, Gustavo A Viani, Andre G Gouveia, et al.
BMC Health Services Research|June 15, 2014
Drug costs in the management of metastatic castration-resistant prostate cancer in CanadaAlice Dragomir, Daniela Dinea, Marie Vanhuyse, et al.
Cancer|February 2, 2016
Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysisChiranjeev Sanyal, Armen G Aprikian, Fabio L Cury, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2024
Neutrophil-to-lymphocyte ratio for the prediction of soft tissue sarcomas response to pre-operative radiation therapyConstanza Martinez, Rie N Asso, Neelabh Rastogi, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Cureus|May 3, 2018
Abscopal Effect in a Stage IV Melanoma Patient who Progressed on PembrolizumabJames M Tsui, Catalin Mihalcioiu, Fabio L Cury
Expert Review of Anticancer Therapy|December 4, 2009
Organ-sparing strategies in the management of invasive bladder cancerFaysal A Yafi, Fabio L Cury, Wassim Kassouf
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 12, 2011
Radiation therapy and androgen deprivation in the management of high risk prostate cancerAlan Dal Pra, Fabio L Cury, Luis Souhami
CMAJ Open|August 1, 2014
Active surveillance for low-risk prostate cancer compared with immediate treatment: a Canadian cost comparisonAlice Dragomir, Fabio L Cury, Armen G Aprikian
Brachytherapy|February 13, 2010
Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapyFabio L Cury, Marie Duclos, Armen Aprikian, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2022
Meta-analysis of Elective Pelvic Nodal Irradiation Using Moderate Hypofractionation for High-Risk Prostate CancerGustavo A Viani, Andre G Gouveia, Fabio Y Moraes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2024
In reply to Niu et al: Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)Fabio L Cury, Gustavo A Viani, Andre G Gouveia, et al.
BMC Health Services Research|June 15, 2014
Drug costs in the management of metastatic castration-resistant prostate cancer in CanadaAlice Dragomir, Daniela Dinea, Marie Vanhuyse, et al.
Cancer|February 2, 2016
Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysisChiranjeev Sanyal, Armen G Aprikian, Fabio L Cury, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2024
Neutrophil-to-lymphocyte ratio for the prediction of soft tissue sarcomas response to pre-operative radiation therapyConstanza Martinez, Rie N Asso, Neelabh Rastogi, et al.
Pageof 6